Valuation: Perrigo Company plc

Market Cap 2.18B 1.96B 1.79B 1.63B 3.07B 205B 3.17B 21.54B 8.59B 109B 8.18B 8.01B 345B P/E 2026 *
-9.79x
P/E 2027 * 196x
Enterprise Value 4.96B 4.45B 4.06B 3.71B 6.99B 466B 7.21B 48.97B 19.53B 249B 18.6B 18.2B 785B EV / Sales 2026 *
1.24x
EV / Sales 2027 * 1.23x
Free-Float
99.61%
Yield 2026 *
7.38%
Yield 2027 * 7.48%
1 day+1.21%
1 week+1.17%
Current month+1.17%
1 month+14.04%
3 months+27.31%
6 months+30.22%
Current year+14.69%
1 week 15.12
Extreme 15.12
16.8
1 month 14
Extreme 14
16.8
Current year 9.22
Extreme 9.225
16.8
1 year 9.22
Extreme 9.225
16.8
3 years 9.22
Extreme 9.225
34.6
5 years 9.22
Extreme 9.225
47.95
10 years 9.22
Extreme 9.225
95.93
Manager TitleAgeSince
Chief Executive Officer 63 07/06/2026
Director of Finance/CFO 51 16/05/2022
Chief Operating Officer - 23/06/2025
Director TitleAgeSince
Director/Board Member 75 01/11/2014
Director/Board Member 61 07/11/2016
Director/Board Member 70 06/02/2017
Date Insider Type Main position Quantity % Market Cap. Importance
11/9/26 Exercice

Director

5,192 0.0037%
11/9/26 Exercice

Director

3,133 0.0023%
9/9/26 Exercice

Executive/Senior Manager

18,186 0.0131%
Change 5-day change 1-year change 3-year change Capi.($)
+1.56%+1.17%+6.93%-43.92% 2.18B
-0.18%-3.98%+45.19%+128.68% 1,216B
+1.12%+0.76%+47.23%+81.46% 656B
+0.48%-1.54%+32.55%+105.63% 509B
-0.36%-3.25%+47.17%+64.58% 384B
-0.21%-1.92%+70.97%+40.55% 362B
-0.78%-0.52%+30.57%+57.98% 311B
-0.80%-0.21%+8.54%+35.56% 293B
+0.16%-0.92%+46.31%+69.24% 249B
+0.05%-1.60%+36.10%+106.99% 208B
Average +0.06%+0.42%+37.16%+64.67% 419B
Weighted average by Cap. +0.06%+0.03%+42.33%+88.53%

Financials

2026 *2027 *
Net sales 4.05B 3.64B 3.32B 3.03B 5.72B 381B 5.9B 40.06B 15.97B 203B 15.22B 14.89B 642B 4.1B 3.68B 3.36B 3.07B 5.79B 386B 5.97B 40.55B 16.17B 206B 15.4B 15.07B 650B
Net income -225M -202M -184M -168M -317M -21.13B -327M -2.22B -886M -11.28B -844M -826M -35.6B -57.65M -51.71M -47.26M -43.14M -81.27M -5.42B -83.83M -570M -227M -2.89B -216M -212M -9.13B
Net Debt 2.78B 2.49B 2.28B 2.08B 3.91B 261B 4.04B 27.42B 10.94B 139B 10.42B 10.2B 440B 2.72B 2.44B 2.23B 2.03B 3.83B 256B 3.95B 26.86B 10.71B 136B 10.21B 9.99B 431B
Projected Income Statement - Annual - Perrigo Company plc
Logo Perrigo Company plc
Perrigo Company plc is a pure-play self-care company. The Company provides health and wellness solutions. Its segments include Self Care, Specialty Care, and Infant Formula. Self Care comprises Upper Respiratory, Digestive Health, Pain & Sleep and Healthy Lifestyle product categories globally. Specialty Care comprises our Women's Health and Skin Health product categories globally. Infant Formula comprises the Infant Formula product category, which includes nutritional products designed to meet the dietary needs of infants. It provides a store-branded private label provider of self-care products in many categories, including upper respiratory, healthy lifestyle and women's health, along with brands including Opill and Mederma. Its Europe portfolio consists primarily of brands, including Compeed, ellaOne, Solpadeine, Jungle Formula, and ACO. Its upper respiratory products include Nasonex 24HR Energy, Mucus DM, All Day Allergy, Nighttime Cold & Flu, and Allergy Relief.
Employees
8,100
Date Price Change Volume
07/11/26 USD 15.88 +1.08% 1,082,721
05/11/26 USD 15.71 -0.76% 2,875,543
04/11/26 USD 15.83 +0.83% 4,972,088
03/11/26 USD 15.70 -0.32% 2,146,726
02/11/26 USD 15.75 -0.19% 2,007,463
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - Perrigo Company plc
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
15.71USD
Average target price
18.00USD
Spread / Average Target
+14.58%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Perrigo Company plc
  1. Stock Market
  2. Stocks
  3. PRGO Stock